IDYA News
IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations Events
IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations Events IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations EventsPR NewswireSOUTH SAN FRANCISCO, Calif., Nov. 4, 2026 SOUTH SAN FRANCISCO, Calif., Nov. 4, 2026 /PRNewswire/ -- IDEAYA...
PR Newswire
IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations Events
IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations Events IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations EventsPR NewswireSOUTH SAN FRANCISCO, Calif., Nov. 4, 2026 SOUTH SAN FRANCISCO, Calif., Nov. 4, 2026 /PRNewswire/ -- IDEAYA...
PR Newswire
IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Tops Revenue Estimates
IDEAYA Biosciences (IDYA) delivered earnings and revenue surprises of +3.18% and +14.69%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update
IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business UpdatePR NewswireSOUTH SAN FRANCISCO, Calif., Nov. 3, 2026 Data presented at ESMO 2026 collectively...
PR Newswire
Vertex Pharmaceuticals (VRTX) Misses Q3 Earnings Estimates
Vertex (VRTX) delivered earnings and revenue surprises of -3.25% and +1.11%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)PR NewswireSOUTH SAN FRANCISCO, Calif., Oct. 30, 2026 SOUTH SAN FRANCISCO, Calif., Oct. 30, 2026 /PRNewswire/ -- IDEAYA Biosciences...
PR Newswire
Earnings Preview: Acadia Pharmaceuticals (ACAD) Q3 Earnings Expected to Decline
Acadia (ACAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IDEAYA Biosciences (IDYA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine Carcinomas
IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine Carcinomas IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates...
PR Newswire
IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma
IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at...
PR Newswire
IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development
IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and DevelopmentPR NewswireSOUTH SAN FRANCISCO, Calif., Sept. 28, 2026 SOUTH SAN FRANCISCO, Calif., Sept. 28...
PR Newswire